Opzelura (ruxolitinib)
pCPA File Number:
23292
Negotiation Status:
Under consideration for negotiation
Indication(s):
Nonsegmental vitiligo
Sponsor/Manufacturer:
Incyte Biosciences Canada Corporation
CDA-AMC Project Number:
SR0835-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable